Video Experimental Relacionado
Updated: Jul 8, 2026
07:59
Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism
Published on: August 19, 2021
La deficiencia de glucosa-6-fosfato deshidrogenasa es una deficiencia de glucosa-6-fosfato.
1Department of Internal Medicine, University of Milan, Policlinico, Mangiagalli, Regina Elena Foundation IRCCS, Via F Sforza 35, Milan, Italy. maria.cappellini@unimi.it
Lancet (London, England)
|January 8, 2008
Resumen
La deficiencia de glucosa-6-fosfato deshidrogenasa (G6PD), el defecto enzimático más común, afecta a más de 400 millones de personas en todo el mundo. Su distribución refleja la malaria, lo que sugiere un efecto protector contra la enfermedad.
Área de la Ciencia:
- Genética La genética.
- La bioquímica es la bioquímica.
- Epidemiología La epidemiología.
Sus antecedentes:
- La deficiencia de glucosa-6-fosfato deshidrogenasa (G6PD) es el defecto enzimático humano más frecuente, que afecta a más de 400 millones de personas en todo el mundo.
- Su distribución geográfica se correlaciona fuertemente con la prevalencia de la malaria, lo que apoya la hipótesis de protección contra la malaria.
- Este trastorno ligado al X surge de mutaciones en el gen G6PD, lo que resulta en diversas presentaciones bioquímicas y clínicas.
Objetivo del estudio:
- Para resumir la base genética, las manifestaciones clínicas y la importancia epidemiológica de la deficiencia de glucosa-6-fosfato deshidrogenasa (G6PD).
- Para resaltar la relación entre la deficiencia de G6PD y la malaria.
- Para describir la comprensión actual de la gestión y el cribado de deficiencias G6PD.
Principales métodos:
- Revisión de la literatura existente sobre la deficiencia de G6PD.
- Análisis de los datos epidemiológicos sobre la deficiencia de G6PD y la distribución de la malaria.
- Compilación de las mutaciones conocidas del gen G6PD y sus fenotipos asociados.
Principales resultados:
- Se han identificado más de 140 mutaciones en el gen G6PD, principalmente cambios de una sola base que causan sustituciones de aminoácidos.
- Las principales características clínicas incluyen ictericia neonatal y anemia hemolítica aguda, a menudo desencadenada por factores externos.
- Algunas variantes conducen a la hemolisis crónica, presentándose como anemia hemolítica no esferocítica congénita.
Conclusiones:
- El manejo efectivo de la deficiencia de G6PD implica prevenir la hemólisis evitando el estrés oxidativo.
- Los programas de detección se implementan en función de la prevalencia local de deficiencia de G6PD.
- La deficiencia de G6PD representa una preocupación significativa para la salud mundial con implicaciones para la dinámica de las enfermedades infecciosas.
Videos de Conceptos Relacionados
01:20Energy-requiring Steps of Glycolysis
Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:21Glycolysis: Preparatory Phase
In cellular metabolism (the complete breakdown of glucose to extract energy), glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:31ATP Energy Storage and Release
ATP is a highly unstable molecule. Unless quickly used to perform work, ATP spontaneously dissociates into ADP and inorganic phosphate (Pi), and the free energy released during this process is lost as heat. The energy released by ATP hydrolysis is used to perform work inside the cell and depends on a strategy called energy coupling. Cells couple the exergonic reaction of ATP hydrolysis with endergonic reactions, allowing them to proceed.
One example of energy coupling using ATP involves a...
One example of energy coupling using ATP involves a...
01:24Other Glycolytic Pathways
The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...